BISMARCK — U.S. Senator Kevin Cramer (R-ND) announced the U.S. Department of Health and Human Services (HHS) awarded North Dakota State University (NDSU) $145,000 for research on Biochemical Characterization of the CAMKV Pseudokinase.

The resources will be administered through the National Center for Advancing Translational Sciences (NCATS), which aims to streamline the development and deployment of disease treatments.